DCVAX-L will not be granted an MAA on the basis of some anecdotal evidence when it was used as a ‘piggy back’ treatment. Hardly, clean empirical evidence, is it. MAA’s are not granted on the basis of ‘maybe’s, possibly’s or might be of a causal benefit .
Market Data 
Markets 
AI
